Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Vijaya Ramachandran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9717-9662; OpenAlex author ID A5101698837. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper

Papers 9

  1. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1126/scitranslmed.aat3487↗
  2. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo. Co-author DOI 10.1159/000445664↗
  3. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. Last author DOI 10.1152/ajpgi.00169.2015↗
  4. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. Co-author DOI 10.1371/journal.pone.0144969↗
  5. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. First author DOI 10.1158/1535-7163.mct-12-0771↗
  6. Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. First author DOI 10.1053/j.gastro.2012.08.044↗
  7. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Co-author DOI 10.1158/1541-7786.mcr-12-0022↗
  8. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. Co-author DOI 10.1371/journal.pone.0042699↗
  9. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Co-author DOI 10.1097/mpa.0b013e31821f6927↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Craig D. Logsdon · 9 shared papers, 2011–2018 · strength 0.41
  2. Thiruvengadam Arumugam · 8 shared papers, 2011–2018 · strength 0.38
  3. Rosa F. Hwang · 3 shared papers, 2011–2018 · strength 0.12
  4. Jia Cao · 2 shared papers, 2015–2016 · strength 0.11
  5. Huamin Wang · 2 shared papers, 2012–2018 · strength 0.10
  6. Liran Zhou · 1 shared paper, 2018 · strength 0.06
  7. Jianhua Ling · 1 shared paper, 2018 · strength 0.06
  8. Yan Liu · 1 shared paper, 2018 · strength 0.06
  9. Paul J. Chiao · 1 shared paper, 2018 · strength 0.06
  10. Anirban Maitra · 1 shared paper, 2018 · strength 0.06
  11. Mien‐Chie Hung · 1 shared paper, 2018 · strength 0.06
  12. Jeffrey E. Lee · 1 shared paper, 2018 · strength 0.06
  13. Michael A. Curran · 1 shared paper, 2018 · strength 0.06
  14. Baoan Ji · 2 shared papers, 2012 · strength 0.06
  15. Jia-Chun Yang · 1 shared paper, 2015 · strength 0.05
  16. Zhao‐Shen Li · 1 shared paper, 2015 · strength 0.05
  17. Leiming Xu · 1 shared paper, 2015 · strength 0.05
  18. Shumei Song · 1 shared paper, 2012 · strength 0.03
  19. Robert S. Bresalier · 1 shared paper, 2012 · strength 0.03
  20. Robert E. Godin · 1 shared paper, 2012 · strength 0.03
  21. Thomas C. Smyrk · 1 shared paper, 2012 · strength 0.02
  22. Gaurav Aggarwal · 1 shared paper, 2012 · strength 0.02
  23. Naureen Javeed · 1 shared paper, 2012 · strength 0.02
  24. Suresh T. Chari · 1 shared paper, 2012 · strength 0.02
  25. Gloria M. Petersen · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.